Paulo J. M. Vieira
9Patents
5h-index
9Co-inventors
48Inventor score
Filing activity: Jul 20, 1992 → Apr 19, 2000
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5231012A | Nucleic acids encoding cytokine synthesis inhibitory factor (interleukin-10) | Emerging Cross-Sectional Technologies | 81 | Expired |
| US6217857A | Cytokine synthesis inhibitory factor (IL-10) and pharmaceutical compositions thereof | Emerging Cross-Sectional Technologies | 32 | Expired |
| US6018036A | Nucleic acids encoding cytokine synthesis inhibitory factor (Interleukin-10) | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6106823A | Treatment of neoplastic disease with interleukin-10 | Chemistry; Metallurgy | 5 | Expired |
| US5827513A | Methods of treating insulin-dependent diabetes mellitus by administration of IL-10 | Human Necessities | 5 | Expired |
| US6207154A | Methods of treatment using antagonists of cytokine synthesis inhibitory factor | Emerging Cross-Sectional Technologies | 2 | Expired |
| US6239260A | Binding compositions specific for interleukin-10 | Emerging Cross-Sectional Technologies | 2 | Expired |
| US6312680A | Methods of treatment using cytokine synthesis inhibitory factor | Emerging Cross-Sectional Technologies | 1 | Expired |
| US6319493A | Treatment of neoplastic disease with interleukin-10 | Chemistry; Metallurgy | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.